MeritValue

AVANOS MEDICAL, INC.

AVNSdata completeness 100%14 fiscal years on file
i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$587M1$684.1M2$673.3M3$687.8M3$701.2M3
Net income$6.3M4$50.5M5−$61.8M6−$392.1M6−$72.9M6
Operating cash flow$87.3M7$90.9M8$32.4M9$100.7M9$74.7M9
Capital expenditure$21M10$19.3M11$17.8M12$17.8M12$31.6M12
Free cash flow (derived)$66.3M7$71.6M8$14.6M9$82.9M9$43.1M9
Total debt$260M13$458.8M13$168M14$134.7M15$100.5M15
Cash & equivalents$118.5M16$127.7M17$87.7M18$107.7M19$89.8M19
Diluted shares48.6M47.3M46.6M46.0M46.3M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
You’d own
0.000022%
of the whole company
Your share of last year’s profit
−$15.75
Your share of its debt
$21.71
Your share of free cash flow
$9.31
iii. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
$12.36
assumptions (10)
  • riskFreeRate4.5%
  • equityRiskPremium5.0%
  • beta100.0%
  • equityWeight85.0%
  • costOfDebtSpread1.5%
  • taxRate21.0%
  • terminalGrowth2.5%
  • projectionYears10
  • fcfGrowth0.0%
  • fcfBase$43.1M
DCF · Growth Exit 5Y
$13.39
assumptions (10)
  • riskFreeRate4.5%
  • equityRiskPremium5.0%
  • beta100.0%
  • equityWeight85.0%
  • costOfDebtSpread1.5%
  • taxRate21.0%
  • terminalGrowth2.5%
  • projectionYears5
  • fcfGrowth0.0%
  • fcfBase$43.1M
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

iv. The price question — last, on purpose
What does today’s price assume?
Type a price. The ledger answers.
Or set your own belief
FCF growth, next 5 years0.0%
Discount rate (WACC)8.78%
Terminal growth2.5%
At your growth, a share is worth $13.39

Default growth 0.0%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.

Sources — the receipts
  1. 10-K · period ending 2021-12-31 · accession 0001606498-24-000018 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K · period ending 2022-12-31 · accession 0001606498-25-000024 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2023-12-31 · accession 0001606498-26-000004 (RevenueFromContractWithCustomerExcludingAssessedTax)
  4. 10-K · period ending 2021-12-31 · accession 0001606498-24-000018 (NetIncomeLoss)
  5. 10-K · period ending 2022-12-31 · accession 0001606498-25-000024 (NetIncomeLoss)
  6. 10-K · period ending 2023-12-31 · accession 0001606498-26-000004 (NetIncomeLoss)
  7. 10-K · period ending 2021-12-31 · accession 0001606498-24-000018 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2022-12-31 · accession 0001606498-25-000024 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2023-12-31 · accession 0001606498-26-000004 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2021-12-31 · accession 0001606498-24-000018 (PaymentsToAcquireProductiveAssets)
  11. 10-K · period ending 2022-12-31 · accession 0001606498-25-000024 (PaymentsToAcquireProductiveAssets)
  12. 10-K · period ending 2023-12-31 · accession 0001606498-26-000004 (PaymentsToAcquireProductiveAssets)
  13. 10-K · period ending 2021-12-31 · accession 0001606498-23-000020 (LongTermDebtNoncurrent)
  14. 10-K · period ending 2023-12-31 · accession 0001606498-25-000024 (LongTermDebtCurrent)
  15. 10-K · period ending 2024-12-31 · accession 0001606498-26-000004 (LongTermDebtCurrent)
  16. 10-K · period ending 2021-12-31 · accession 0001606498-23-000020 (CashAndCashEquivalentsAtCarryingValue)
  17. 10-K · period ending 2022-12-31 · accession 0001606498-24-000018 (CashAndCashEquivalentsAtCarryingValue)
  18. 10-K · period ending 2023-12-31 · accession 0001606498-25-000024 (CashAndCashEquivalentsAtCarryingValue)
  19. 10-K · period ending 2024-12-31 · accession 0001606498-26-000004 (CashAndCashEquivalentsAtCarryingValue)